|  Help  |  About  |  Contact Us

Publication : Jmjd2b antagonizes H3K9 trimethylation at pericentric heterochromatin in mammalian cells.

First Author  Fodor BD Year  2006
Journal  Genes Dev Volume  20
Issue  12 Pages  1557-62
PubMed ID  16738407 Mgi Jnum  J:109728
Mgi Id  MGI:3629551 Doi  10.1101/gad.388206
Citation  Fodor BD, et al. (2006) Jmjd2b antagonizes H3K9 trimethylation at pericentric heterochromatin in mammalian cells. Genes Dev 20(12):1557-62
abstractText  Histone lysine trimethyl states represent some of the most robust epigenetic modifications in eukaryotic chromatin. Using a candidate approach, we identified the subgroup of murine Jmjd2 proteins to antagonize H3K9me3 at pericentric heterochromatin. H3K27me3 and H4K20me3 marks are not impaired in inducible Jmjd2b-GFP cell lines, but Jmjd2b also reduces H3K36 methylation. Since recombinant Jmjd2b appears as a very poor enzyme, we applied metabolic labeling with heavy methyl groups to demonstrate Jmjd2b-mediated removal of chromosomal H3K9me3 as an active process that occurs well before replication of chromatin. These data reveal that certain members of the jmjC class of hydroxylases can work in a pathway that actively antagonizes a histone lysine trimethyl state.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

4 Bio Entities

0 Expression